These substances, Abacavir Sulfate, Abarelix, and Abiraterone Acetate, each possess unique chemical structures leading to their varying pharmacological effects. Abacavir Sulfate, a nucleoside reverse transcriptase inhibitor, is readily detected via its molecular formula – C14H15N6O4·H2SO4 – and characteristic luminescent properties observed in techniques such as mass spectrometry and infrared assessment. Abarelix, a gonadotropin-releasing hormone (GnRH) receptor inhibitor, presents with a complex peptide sequence, typically requiring amino acid sequencing and peptide mapping for complete identification. Finally, Abiraterone Acetate, a CYP17 inhibitor utilized in prostate tumor treatment, can be verified through its particular mass and fragmentation patterns acquired through gas chromatography-mass spectrometry (GC-MS) alongside nuclear magnetic resonance (NMR) spectroscopic data, ensuring its correct chemical characterization.
Directory: Abacavir Disulfate Sulfate (CAS 188062-50-2) & Connected Materials
Explore the extensive product detailing Abacavir Sulfate Sulfate, identified by CAS number 188062-50-2, and a selection of connected compounds. Our provision includes multiple levels to fulfill more info precise research and production demands. Discover detailed information including analytical information and available containers options. Additionally, examine our selection of structurally cognate materials that may be beneficial in a latest project. The listing is intended to facilitate streamlined acquiring of pure pharmaceutical ingredients.
Pharmaceutical Index: Abarelis and Abirateron Acetate Registry Codes
For scientists and pharmaceutical professionals needing precise drug identification, precise Chemical Abstract Service numbers are crucial. Specifically, abarelix, a hormone-releasing hormone antagonist used in treating prostate disease, is assigned the CAS code 65572-21-8. Furthermore, abiraterone acetate, a key medication in prostate disease, carries the Chemical Abstract Service identifier 389292-17-3. Careful recording and confirmation of these Registry identifiers are imperative to verify correct molecule recognition and following procedures. These codes are freely available through various scientific resources. Regularly check official references for the current data.
Drug Substances: Abacavir Sodium , Abarelix, Abiraterone , Registry Listings
The identification of critical pharmaceutical ingredients often relies on precise chemical identifiers. Specifically, this section succinctly covers three important instances: Abacavir Sodium, a pyrimidine reverse polymerase inhibitor; , a gonadotropin-releasing stimulator; and Abiraterone, utilized in tumor treatment. These molecule is linked with a unique Chemical Abstracts Service number, providing a universal method for identifying data and verifying precise communication within the scientific industry. View the respective resources for complete entries and connected information.
CAS Registry Number Database: Information for Abacavir Sulfate, Abarelix, Abiraterone Acetate
The extensive Chemical Abstracts Service (CAS) registry is an essential resource for chemists and manufacturing professionals alike. This piece quickly explores records pertaining to three significant medicinal compounds: Abacavir Sulfate Salt, a nucleoside reverse transcriptase inhibitor used to treat HIV; Abarelix Acetate, a medication utilized in treatment; and Abiraterone Acetate, a powerful medication used in the management of metastatic advanced cancer. Accessing the accurate CAS identification for each compound allows for unambiguous identification and facilitates correct literature exploration. These individual identifiers are vital for compound validation and uniform reporting across the scientific community.
Leveraging Web API Substance Data: Item Determination with CAS Registry Numbers
Accurate compound identification is paramount in the chemical industry, and API chemical data provides a reliable answer. Specifically, CAS Registry numbers act as distinct identifiers for chemical substances, allowing effortless integration with repositories and systems. Such methodology furthermore bolsters data accuracy but also simplifies procedures related to analysis, acquisition, and legal submission. Additionally, accessing this data via an Application Programming Interface promotes efficiency and reduces the potential for human error.